KRT20 Antikörper (AA 196-323)
-
- Target Alle KRT20 Antikörper anzeigen
- KRT20 (Keratin 20 (KRT20))
-
Bindungsspezifität
- AA 196-323
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser KRT20 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), Staining Methods (StM)
- Spezifität
- This MAb recognizes an intermediate filament protein of 46 kDa, identified as cytokeratin 20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions.It has been detected in adenocarcinomas of the colon, stomachand biliary tract. Breast carcinomas are generally non-reactive.
- Aufreinigung
- Purified by Protein A/G
- Immunogen
- Recombinant fragment of human KRT20 protein (around aa 196-323) (exact sequence is proprietary)
- Klon
- KRT20-3145
- Isotyp
- IgG kappa
- Top Product
- Discover our top product KRT20 Primärantikörper
-
anti-Keratin 20 (KRT20) antibody
KRT20 Reaktivität: Human WB, IF, IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 20 (KRT20) (AA 1-424) antibodyKRT20 Reaktivität: Human WB, ELISA, IF, IHC (p) Wirt: Maus Monoclonal 2G3-1C8 unconjugated
anti-Keratin 20 (KRT20) (AA 245-424) antibodyKRT20 Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 20 (KRT20) (AA 196-323) antibodyKRT20 Reaktivität: Human WB, IHC, StM Wirt: Maus Monoclonal KRT20-1992 unconjugated
anti-Keratin 20 (KRT20) (AA 196-323) antibodyKRT20 Reaktivität: Human WB, IHC, StM Wirt: Maus Monoclonal KRT20-1991 unconjugated
anti-Keratin 20 (KRT20) (AA 1-266) antibodyKRT20 Reaktivität: Human WB, IHC, IHC (p) Wirt: Maus Monoclonal 4A2 unconjugated
anti-Keratin 20 (KRT20) antibodyKRT20 Reaktivität: Human, Maus WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 20 (KRT20) (AA 1-150) antibodyKRT20 Reaktivität: Human IHC, ELISA Wirt: Maus Monoclonal 2C7B9 unconjugated
anti-Keratin 20 (KRT20) (AA 196-323) antibodyKRT20 Reaktivität: Human WB, IHC, StM Wirt: Kaninchen Monoclonal KRT20-3129R unconjugated Recombinant Antibody
anti-Keratin 20 (KRT20) (AA 9-424) antibodyKRT20 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Positive Control: HT29 cells. Colon Carcinoma.
Known Application: Immunohistochemistry (Formalin-fixed) (0.1-0.2 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 200 μg/mL
- Buffer
- 10 mM PBS with 0.05 % BSA & 0.05 % azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-80 °C
- Informationen zur Lagerung
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
- Haltbarkeit
- 24 months
-
- Target
- KRT20 (Keratin 20 (KRT20))
- Andere Bezeichnung
- KRT20 (KRT20 Produkte)
- Synonyme
- KRT20 antikoerper, CD20 antikoerper, CK-20 antikoerper, CK20 antikoerper, K20 antikoerper, KRT21 antikoerper, Krt21 antikoerper, 9030623C06Rik antikoerper, keratin 20 antikoerper, KRT20 antikoerper, Krt20 antikoerper
- Molekulargewicht
- 46kDa
- Gen-ID
- 54474
- UniProt
- P35900
-
